Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients - A randomized study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 113, Issue 1, 2004, Pages 94-97

  Lehoczky, Ottó ^a   Udvary, János ^a   Bagaméri, Andrea ^a   Pulay, Tamás ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Antiemesis; Cisplatin induced emesis; Granisetron; Methylprednisolone

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; GRANISETRON; METHYLPREDNISOLONE; STEROID;

ADULT; AGED; ANTIEMETIC ACTIVITY; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; VOMITING;

EID: 1442335379     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00334-8     Document Type: Article

References (20)

1. Roila F., Ballatori E., Tonato M., Del Favero A. 5-HT3 receptor antagonists: differences and similarities. Eur. J. Cancer. 33:1997;1364-1370.
2. Chua D.T., Sham J.S., Kwonk C.C., Yue A., Foo Y.C., Chan R. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study. Am. J. Clin. Oncol. 23:2000;85-91.
3. Kirchner V., Aapro M., Terrey J.P., Alberto P. A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapy. Eur. J. Cancer. 33:1997;1605-1610.
4. Lehoczky O., Bagameri A., Udvary J., Sarosi Z., Pulay T. Evaluation of antiemetic effectivity of combination with granisetron and methylprednisolone in chemotherapies of gynecological cancer patients. Magyar Nöorvosok Lapja. 64:2001;395-398. [in Hungarian].
5. Italian Group for Antiemetic Research. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 1995;332:1-5.
6. Hesketh P.J., Harvey W.H., Harker W.G.et al. A randomized double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J. Clin. Oncol. 12:1994;596-600.
7. Dogliotti L., Antonacci R.A., Paze E., Ortega C., Berutti A., Faggiuolo R. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. Drugs. 43(3):1992;6-10.
8. Handberg J., Wessel V., Larsen L., Herrstedt J., Hansen H.H. Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy. Support. Care Cancer. 6:1998;63-67.
9. Kleisbauer J.P., Garcia-Giron C., Antimi M.et al. Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesis. Anticancer Drugs. 9:1998;387-392.
10. Carmichael J., Bessel E.M., Harris A.L., Hutcheon A.W., Dawes P.J.D.K., Daniels S. Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis. Br. J. Cancer. 70:1994;1161-1164.
11. Silva R.R., Bascioni R., Giorgi F., Acito L., Giustini L., De Signoribus Marcellini M. Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy. Support. Care Cancer. 4:1996;287-290.
12. Martoni A., Piana E., Strocchi E.et al. Comparative crossover trial of two intravenous doses of granisetron (1. mg vs. 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis Anticancer Res. 18:1998;2799-2803.
13. Italian Group of Antiemetic Research. Ondansetron versus granisetron both combined with dexamethasone in the prevention of cisplatin-induced emesis. Ann Oncol 1995;6:805-10.
14. Hirota T., Shimizu H., Fujimoto T.et al. Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy. Gan To Kagaku Ryoho. 21:1994;91-96. [in Japanese].
15. Ono K., Uchida I., Uno N.et al. Efficacy of combination with granisetron and methylprednisolone for nausea vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia - a randomized comparative trial between granisetron alone and granisetron plus methylprednisolone. Gan To Kagaku Ryoho. 26:1999;821-828. [in Japanese].
16. Sigsgaard T., Herrstedt J., Christensen P., Andersen O., Dombernowsky P. Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy. Support. Care Cancer. 8:2000;233-237.
17. Krzakowski M., Graham E., Goedhals L.et al. A multicenter double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study Group. Anticancer Drugs. 9:1998;593-598.
18. Sorbe B., Hogberg T., Himmelmann A.et al. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone by cisplatin-containing chemotherapy. Eur. J. Cancer. 30A:1994;629-634.
19. Münstedt K., Müller H., Blauth-Eckmeyer E., Stenger K., Zygmunt M., Vahrson H. Role of dexamethasone dosage in combination with 5-HT3 antagonist for prophylaxis of acute chemotherapy-induced nausea and vomiting. Br. J. Cancer. 79:1999;637-639.
20. Italian Group for Antiemetic Research. Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis. J Clin Oncol 1998;16:2937-42.